WEG, a global leader in transformer production, announced a $77 million expansion in Washington, Missouri, that will create ...
WEG will invest $77M to expand in Washington, Missouri. Plus, Warren Head Business Park is named a Missouri Certified Site.
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback